Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 1.470 | 1.590 | 0.120 |
Stocks | 97.640 | 97.640 | 0.000 |
Bonds | 0.010 | 0.010 | 0.000 |
Preferred | 0.880 | 0.880 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 17.759 | 17.651 |
Price to Book | 2.915 | 2.829 |
Price to Sales | 1.821 | 2.013 |
Price to Cash Flow | 10.182 | 11.603 |
Dividend Yield | 1.668 | 2.124 |
5 Years Earnings Growth | 9.257 | 10.940 |
Name | Net % | Category Average |
---|---|---|
Technology | 35.860 | 21.932 |
Industrials | 22.300 | 12.114 |
Consumer Cyclical | 19.180 | 10.616 |
Financial Services | 7.190 | 15.514 |
Communication Services | 6.270 | 7.296 |
Basic Materials | 5.120 | 4.389 |
Healthcare | 2.050 | 14.355 |
Real Estate | 2.030 | 2.787 |
Number of long holdings: 97
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Microsoft Corp | - | 5.54 | - | - | |
Apple Inc | - | 3.93 | - | - | |
NVIDIA Corp | - | 3.87 | - | - | |
Alphabet Inc Class C | - | 3.63 | - | - | |
Amazon.com Inc | - | 2.74 | - | - | |
Citigroup Inc | - | 2.14 | - | - | |
Broadcom Inc | - | 2.13 | - | - | |
Tesla | US88160R1014 | 2.03 | 178.74 | +0.45% | |
Elevance Health Inc | - | 2.00 | - | - | |
Salesforce Inc | - | 1.98 | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Azioni Strategia Flessibile Class r | 5.15B | 2.76 | 0.74 | 3.15 | ||
Azioni Strategia Flessibile Class z | 5.15B | 3.06 | 1.63 | 4.00 | ||
Azioni Strategia Flessibile Class e | 5.15B | 3.07 | 1.63 | 4.01 | ||
LU1341630033 | 5.07B | 9.79 | 9.87 | - | ||
LU1344899445 | 5.07B | 10.62 | 4.37 | - |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review